Pangen Biotech Inc. Logo

Pangen Biotech Inc.

Develops and manufactures biopharmaceuticals and offers CDMO services.

222110 | KO

Overview

Corporate Details

ISIN(s):
KR7222110009
LEI:
Country:
South Korea
Address:
경기도 수원시 영통구 신원로 306, 2동 4층(원천동 영통이노플렉스) , 수원시

Description

Pangen Biotech Inc. is a biotechnology company specializing in the research, development, and manufacturing of biopharmaceuticals. The company utilizes its proprietary platform technologies, particularly those based on Chinese Hamster Ovary (CHO) cell lines, for the production of complex protein therapeutics. Its primary business activities include the development of a pipeline of biosimilar products, such as Erythropoietin (EPO) and Aflibercept. In addition to its own product pipeline, Pangen Biotech offers Contract Development and Manufacturing Organization (CDMO) services, providing expertise in cell line development and biopharmaceutical production to other firms. The company also supplies reagents and kits for research applications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-12-14 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean 12.7 KB
2023-11-13 00:00
분기보고서 (2023.09)
Korean 1.1 MB
2023-10-30 00:00
임시주주총회결과
Korean 6.0 KB
2023-10-18 00:00
단일판매ㆍ공급계약체결
Korean 9.6 KB
2023-10-16 00:00
[기재정정]주주총회소집결의(임시주주총회)
Korean 16.0 KB
2023-10-16 00:00
[기재정정]주주총회소집공고
Korean 73.7 KB
2023-10-13 00:00
[기재정정]주주총회소집결의(임시주주총회)
Korean 17.8 KB
2023-10-13 00:00
주주총회소집공고
Korean 71.8 KB
2023-09-27 00:00
[기재정정]주주총회소집결의
Korean 9.9 KB
2023-09-20 00:00
전환가액의조정
Korean 11.0 KB
2023-08-25 00:00
투자판단관련주요경영사항(빈혈치료제인 팬포틴프리필드시린지주 6000IU 및 10000IU 품목허가 획득))
Korean 7.1 KB
2023-08-21 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2023-08-21 00:00
주주총회소집결의(임시주주총회)
Korean 6.3 KB
2023-08-21 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.3 KB
2023-08-21 00:00
주식등의대량보유상황보고서(일반)
Korean 75.4 KB

Automate Your Workflow. Get a real-time feed of all Pangen Biotech Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pangen Biotech Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pangen Biotech Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.